With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global biotech leader.

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Vor Bio, Korro Bio, Insitro and Rallybio revealed plans to lay off chunks of their respective workforces in the latest job ...

The biotechnology company said it had a quarterly loss of $116.2 million, or 36 cents a share, compared with a loss of $113 million, or 42 cents a share, in the same quarter last year. Analysts polled ...

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

"We are thrilled to welcome Jason to BlossomHill and look forward to him helping the company make transformational leaps ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

A nonprofit incubator said it will take over a 33,000-square-foot building in Richmond, which also possesses manufacturing ...

A live audio webcast of the fireside chat will also be available to the general public and can be accessed at ...

We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...

In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening performed in a doctor's office.

South Korea has launched a new immigration initiative, the Top-Tier Visa Program (F-2 Resident Visa), targeted at highly skilled foreign ...